McKesson (MCK) Stock Price, News & Analysis

Company Overview

McKesson Corporation (NYSE:MCK) is a healthcare services and information technology company that distributes pharmaceuticals, specialty drugs, medical supplies and other healthcare products. The company serves pharmacies, hospitals, health systems, physician practices, biopharma manufacturers and other healthcare providers, helping move products from manufacturers to patients and care settings.

McKesson’s principal operations include pharmaceutical distribution, medical-surgical supply distribution and technology-enabled services for pharmacies and providers. Its specialty businesses support areas such as oncology and other complex therapies, while its technology and services offerings help customers manage prescriptions, practice operations, patient access and medication-related programs.

Founded in 1833, McKesson has developed from a wholesale drug business into a broad healthcare-services company. Its operations primarily serve customers in the United States, with additional activities in selected international markets. The company is headquartered in Irving, Texas, and is led by President and Chief Executive Officer Brian Tyler.

Key Stats

• Today's Range: $881.34 to $924.21
• 50-Day Range: $825.00 to $927.16
• 52-Week Range: $723.68 to $999.00
• Volume: 1.21 million shs
• Average Volume: 944,365 shs
• Market Capitalization: $105.09 billion
• P/E Ratio: 24.12
• Dividend Yield: 0.42%
• Price Target: $973.44
• Consensus Rating: Moderate Buy

McKesson Stock Analysis - MarketRank™

McKesson scored higher than 84% of companies evaluated by MarketBeat, and ranked 74th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

McKesson has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 14 buy ratings, 4 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for McKesson is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

McKesson has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 11.63%

Earnings Growth

Earnings for McKesson are expected to grow by 11.63% in the coming year, from $44.64 to $49.83 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of McKesson is 24.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.83.

Price to Earnings Ratio vs. Sector

The P/E ratio of McKesson is 24.12, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.83.

Price to Earnings Growth Ratio

McKesson has a PEG Ratio of 1.72. PEG Ratios above 1 indicate that a company could be overvalued.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.49% of the float of McKesson has been sold short.

Short Interest Ratio / Days to Cover

McKesson has a short interest ratio ("days to cover") of 3.39, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in McKesson has recently increased by 2.42%, indicating that investor sentiment is decreasing.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

McKesson has a dividend yield of 0.43%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

McKesson has been increasing its dividend for 17 years.

Dividend Coverage

The dividend payout ratio of McKesson is 10.06%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, McKesson will have a dividend payout ratio of 7.55% next year. This indicates that McKesson will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.37

News Sentiment

McKesson has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for McKesson this week, compared to 7 articles on an average week.

Search Interest

Only 12 people have searched for MCK on MarketBeat in the last 30 days. This is a decrease of -54% compared to the previous 30 days.

MarketBeat Follows

Only 7 people have added McKesson to their MarketBeat watchlist in the last 30 days. This is a decrease of -30% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, McKesson insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,083,441.00 in company stock.

Percentage Held by Insiders

0.06% of the stock of McKesson is held by insiders.

Percentage Held by Institutions

85.07% of the stock of McKesson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Record date for 10/1 Dividend: 9/01/2026
• Ex-Dividend for 10/1 Dividend: 9/01/2026
• Today: 10/01/2026
• Dividend Payable: 10/01/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Distributors
• Current Symbol: NYSE:MCK
• CIK: 927653
• Web: www.mckesson.com
• Phone: (972) 446-4800
• Fax: 415-983-8453
• Employees: 43,000
• Year Founded: 1833

Price Target and Rating

• Average Price Target for McKesson: $973.44
• High Price Target: $1,085.00
• Low Price Target: $845.00
• Potential Upside/Downside: +8.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.78
• Research Coverage: 18 Analysts

Profitability

• EPS (Trailing Twelve Months): $37.37
• Trailing P/E Ratio: 24.12
• Forward P/E Ratio: 20.19
• P/E Growth: 1.72
• Net Income: $4.76 billion
• Net Margins: 1.12%
• Pretax Margin: 1.57%
• Return on Equity: -253.21%
• Return on Assets: 5.90%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.89
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $403.43 billion
• Price / Sales: 0.26
• Cash Flow: $47.49 per share
• Price / Cash Flow: 18.98
• Book Value: ($14.51) per share
• Price / Book: -62.12

Miscellaneous

• Outstanding Shares: 116,590,000
• Free Float: 116,520,000
• Market Cap: $105.09 billion
• Optionable: Optionable
• Beta: 0.30